GlobalData on MSN20h
EC approves MSD’s pneumococcal 21-valent conjugate Capvaxive
The decision was influenced by the positive recommendation from the EMA’s Committee for Medicinal Products for Human Use.
Zacks.com on MSN15h
Merck Gets EC Nod for 21-Valent Pneumococcal Jab Capvaxive
The European Commission approves MRK's pneumococcal 21-valent conjugate vaccine, Capvaxive, for pneumococcal vaccination in ...
Pharmabiz3h
Merck’s Capvaxive receives European approval for prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults
Merck’s Capvaxive receives European approval for prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults: Rahway, New Jersey Friday, March 28, 2025, 09: ...
Exclusive: FDA staff struggle to meet product review deadlines after DOGE layoffs
Some U.S. health regulators who review medical devices and tobacco products for safety and efficacy are struggling to meet ...
Makary’s FDA Has Options In Industry Fight Over Weight Loss Drugs
Americans pay far more for GLP-1 drugs than citizens in other wealthy nations. If Dr. Marty Makary, the new FDA commissioner, ...